Erle T. Mast, Executive VP and CFO at Clovis Oncology, Inc. (CLVS), sold 3,000 shares at $86.04 ($266K) on 2015-06-01, disclosed to the SEC on 2015-06-03.
Scheduled sale ($266k) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.04 | 200 | $17K | 6.5% |
| 2 | $87.64 | 900 | $79K | 29.6% |
| 3 | $88.90 | 1,000 | $89K | 33.4% |
| 4 | $89.99 | 500 | $45K | 16.9% |
| 5 | $90.87 | 400 | $36K | 13.6% |
| Total | $88.78 avg | 3,000 |
| $266K |
| 100% |
| Filing → |
| SNNA | BUY | 2017-08-01 | $101K | — | Filing → |
| CLVS | SELL | 2015-11-03 | $317K | — | Filing → |
| CLVS | SELL | 2015-10-02 | $271K | — | Filing → |